INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER (Singapore–4:45 p.m. SPT/3:45 a.m. EST January 30, 2021–Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International Association for the Study of Lung Cancer’s 2020 World...
Tag: <span>immunotherapy treatment</span>
Post
Researchers develop new drug that fights cancer with less renal toxicity
by National University of Singapore A team of pharmacists and chemists from the National University of Singapore (NUS) has developed a new anti-cancer drug that has less toxic effects to the kidneys. The new drug works like a “magic bullet” that is delivered directly to the mitochondria—the power generators of cells—of cancer cells. Once the drug reaches the tumor, two active molecules—an anti-cancer drug and a sensitizer—are released at once,...
Post
Immunotherapy treatment option for selected breast cancer patients, genetic study suggests
Existing immunotherapy drugs could help some breast cancer patients, based on the genetic changes in their tumors Immunotherapy drugs could help some breast cancer patients based on the genetic changes in their tumours, researchers at the Wellcome Trust Sanger Institute and their collaborators find. Published today (13 September) in Cancer Research, scientists identify particular genetic changes...
Post
Testing a new immunotherapy treatment for neuroblastoma
T cells are important fighters against disease. Immunotherapies are changing the outlook for many cancer patients. Drugs that block cancer cells from deflecting an immune attack are now routinely used to treat advanced skin and kidney cancers, and are showing promise in other types of cancer too. But cancers are complex and diverse – what works...